Exagen Inc. to Participate in Third Quarter Investor Conferences

Rhea-AI Summary

Exagen (NASDAQ:XGN), a provider of innovative autoimmune testing solutions, has announced its participation in two upcoming investor conferences. The company will engage in fireside chats and one-on-one meetings at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, in Boston, and the Cantor Global Healthcare Conference 2025 on September 3, 2025, in New York City.

CARLSBAD, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, today announced that management will participate in the following upcoming investor conferences:

Canaccord Genuity 45^th Annual Growth Conference

Participation: Fireside Chat and 1X1 Meetings

Date: Tuesday, August 12, 2025

Location: InterContinental Hotel in Boston, MA

Cantor Global Healthcare Conference 2025

Participation: Fireside Chat and 1X1 Meetings

Date: Wednesday, September 3, 2025

Location: Marriott Marquis Hotel in NY, NY

About Exagen

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE^® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s disease earlier and with greater accuracy. Exagen’s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.

For more information, visit Exagen.com or follow @ExagenInc on X.

Investors:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525

FAQ

When is Exagen (XGN) presenting at the Canaccord Genuity Growth Conference 2025?

Exagen will participate in a fireside chat and 1-on-1 meetings on Tuesday, August 12, 2025 at the InterContinental Hotel in Boston, MA.

Where is the Cantor Global Healthcare Conference 2025 for Exagen being held?

The conference will be held at the Marriott Marquis Hotel in New York City on Wednesday, September 3, 2025.

What type of meetings will Exagen (XGN) participate in at these investor conferences?

Exagen will participate in fireside chat discussions and one-on-one meetings at both conferences.

What does Exagen (XGN) specialize in as a company?

Exagen is a leading provider of innovative autoimmune testing solutions.